Your browser doesn't support javascript.
loading
Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report.
Chen, Yuanbin; Paz-Ares, Luis; Reinmuth, Niels; Garassino, Marina Chiara; Statsenko, Galina; Hochmair, Maximilian J; Özgüroglu, Mustafa; Verderame, Francesco; Havel, Libor; Losonczy, György; Conev, Nikolay V; Hotta, Katsuyuki; Ji, Jun Ho; Spencer, Stuart; Dalvi, Tapashi; Jiang, Haiyi; Goldman, Jonathan W.
Affiliation
  • Chen Y; Cancer and Hematology Centers of Western Michigan, Grand Rapids, Michigan.
  • Paz-Ares L; Department of Medical Oncology, Hospital Universitario 12 de Octubre, Madrid, Spain.
  • Reinmuth N; Department of Thoracic Oncology, Asklepios Lung Clinic, Munich-Gauting, Germany.
  • Garassino MC; Fondazione Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Istituto Nazionale dei Tumori, Milan, Italy.
  • Statsenko G; Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois.
  • Hochmair MJ; Omsk Regional Cancer Center, Omsk, Russia.
  • Özgüroglu M; Department of Respiratory and Critical Care Medicine, Karl Landsteiner Institute of Lung Research and Pulmonary Oncology, Krankenhaus Nord, Vienna, Austria.
  • Verderame F; Division of Medical Oncology, Department of Internal Medicine, Cerrahpasa School of Medicine, Istanbul University-Cerrahpasa, Istanbul, Turkey.
  • Havel L; Azienda Ospedaliera (AO) Ospedali Riuniti Presidio Ospedaliero (PO) Vincenzo Cervello, Palermo, Italy.
  • Losonczy G; Department of Pneumology, First Faculty of Medicine, Thomayer Hospital, Charles University, Prague, Czechia.
  • Conev NV; Department of Pulmonology, Semmelweis University, Budapest, Hungary.
  • Hotta K; Medical Oncology, UMHAT St Marina, Varna, Bulgaria.
  • Ji JH; Center for Innovative Clinical Medicine, Okayama University Hospital, Okayama, Japan.
  • Spencer S; Department of Internal Medicine, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, South Korea.
  • Dalvi T; AstraZeneca, Cambridge, United Kingdom.
  • Jiang H; AstraZeneca, Gaithersburg, Maryland.
  • Goldman JW; AstraZeneca, Gaithersburg, Maryland.
JTO Clin Res Rep ; 3(6): 100330, 2022 Jun.
Article in En | MEDLINE | ID: mdl-35719865

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: JTO Clin Res Rep Year: 2022 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials Language: En Journal: JTO Clin Res Rep Year: 2022 Document type: Article Country of publication: